Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Sodium channel protein type 5 subunit alpha | ||
Ligand | BDBM50370682 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1478541 (CHEMBL3430442) | ||
IC50 | 6310±n/a nM | ||
Citation | Mirams, GR; Davies, MR; Brough, SJ; Bridgland-Taylor, MH; Cui, Y; Gavaghan, DJ; Abi-Gerges, N Prediction of Thorough QT study results using action potential simulations based on ion channel screens. J Pharmacol Toxicol Methods70:246-54 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Sodium channel protein type 5 subunit alpha | |||
Name: | Sodium channel protein type 5 subunit alpha | ||
Synonyms: | HH1 | SCN5A | SCN5A_HUMAN | Sodium channel alpha subunit | Sodium channel protein type 5 subunit alpha/beta-1/beta-2 | Sodium channel protein type V alpha subunit | Voltage-gated sodium channel subunit alpha Nav1.5 | ||
Type: | Enzyme | ||
Mol. Mass.: | 226908.60 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q14524 | ||
Residue: | 2016 | ||
Sequence: |
| ||
BDBM50370682 | |||
n/a | |||
Name | BDBM50370682 | ||
Synonyms: | SOLIFENACIN | ||
Type | Small organic molecule | ||
Emp. Form. | C23H26N2O2 | ||
Mol. Mass. | 362.4647 | ||
SMILES | [H]C12CCN(CC1)C[C@@H]2OC(=O)N1CCc2ccccc2[C@@H]1c1ccccc1 |wD:8.10,21.25,TLB:9:8:2.3:6.5,(23.54,-9.18,;23.57,-7.64,;22.04,-8.3,;21.84,-6.92,;23.31,-6.28,;23.38,-4.63,;23.82,-5.74,;24.65,-6.88,;24.94,-8.28,;24.93,-9.81,;23.59,-10.56,;22.26,-9.79,;23.59,-12.1,;24.92,-12.9,;24.88,-14.45,;23.53,-15.19,;23.52,-16.72,;22.17,-17.47,;20.85,-16.68,;20.87,-15.14,;22.21,-14.39,;22.23,-12.84,;20.91,-12.06,;19.57,-12.81,;18.25,-12.02,;18.28,-10.47,;19.62,-9.73,;20.94,-10.52,)| | ||
Structure |